Opportunities and Challenges for Clinical Trials
The momentum and muscle behind “finding the right drug for the right patient at the right dose” has further escalated with former President Barack Obama’s announcement of a $215 million dollar Precision Medicine Initiative. In this webinar, Dr. Frank Smith explores the advances in precision medicine and how it affects clinical research. As a pediatric hematologist/oncologist, he uses his extensive clinical and research background as a backdrop for the discussion.
- The evolution of “personalized medicine” to “precision medicine”
- How state-of-the-art molecular biology is creating new diagnostic and prognostic strategies
- How these new strategies are helping inform the design of clinical trials
- Case study: How precision medicine is improving clinical trials in hematology and oncology
Franklin O. Smith III, MD – Vice President Medical Affairs, Hematology and Oncology, Medpace
Dr. Smith is an industry leader in hematologic malignancies, stem cell transplantation, bone marrow failure syndromes, and childhood cancers. In addition to being a pioneer in hematologic oncology and cord blood transplantation, he is a highly-regarded author, speaker, and industry participant.